Prof. Dr. Matthias Beckmann

Lehrstuhl für Geburtshilfe und Frauenheilkunde

IMPAIRED GENE-EXPRESSION AND EPIGENETIC REGULATION OF RETINOIC ACID RECEPTOR RESPONDER 1 IN PREECLAMPSIA AND CHORIOCARCINOMA (2016) Hübner H, Fahlbusch FB, Strissel P, Strick R, Wachter D, Beckmann M, Rübner M Conference contribution From the Past to the Future The 1st Volume of "Obstetrics and Women's Medicine - Research Findings for Practice". A Review of the 75th Birthday (2016) Ebert AD, Beckmann M, Wallwiener D, David M Journal article, Review article Oncological heath care networks. The triangle formed by research, quality, and competition (2016) Schrauder MG, Bamberg M, Beckmann M Journal article New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018 Statement of the Gynecology Oncology Working Group (AGO) (2016) Hillemanns P, Mallmann P, Beckmann M Journal article Modern systemic therapy concepts in cervical cancer. Innovations from the S3 guideline: "Diagnosis, treatment and after care of the patient with cervical cancer" (2016) Koch M, Mehlhorn G, Beckmann M Journal article Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015) (2016) Tempfer C, Horn LC, Ackermann S, Beckmann M, Dittrich R, Einenkel J, Guenthert A, et al. Journal article BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers (2016) Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, et al. Journal article Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline (2016) Almstedt K, Fasching P, Scharl A, Rauh C, Rack B, Hein A, Hack C, et al. Journal article rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk (2016) Liu J, Loncar I, Collee JM, Bolla MK, Dennis J, Michailidou K, Wang Q, et al. Journal article An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression (2016) Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, et al. Journal article